These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 28754964)

  • 1. Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis.
    Zhang Q; Dong P; Liu X; Sakuragi N; Guo SW
    Sci Rep; 2017 Jul; 7(1):6804. PubMed ID: 28754964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis.
    Proestling K; Birner P; Gamperl S; Nirtl N; Marton E; Yerlikaya G; Wenzl R; Streubel B; Husslein H
    Reprod Biol Endocrinol; 2015 Jul; 13():75. PubMed ID: 26198055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor 1α-induced epithelial-mesenchymal transition of endometrial epithelial cells may contribute to the development of endometriosis.
    Xiong Y; Liu Y; Xiong W; Zhang L; Liu H; Du Y; Li N
    Hum Reprod; 2016 Jun; 31(6):1327-38. PubMed ID: 27094478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.
    Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Zhao J; Vieth E; Nephew KP; Matei D
    Oncotarget; 2016 Dec; 7(51):84453-84467. PubMed ID: 27563817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Expression of Eukaryotic Translation Initiation Factor 3 Subunit e and Its Possible Involvement in the Epithelial-Mesenchymal Transition in Endometriosis.
    Cai X; Shen M; Liu X; Guo SW
    Reprod Sci; 2018 Jan; 25(1):102-109. PubMed ID: 28438065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial to mesenchymal transition (EMT) seems to be regulated differently in endometriosis and the endometrium.
    Bartley J; Jülicher A; Hotz B; Mechsner S; Hotz H
    Arch Gynecol Obstet; 2014 Apr; 289(4):871-81. PubMed ID: 24170160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.
    Chang JW; Gwak SY; Shim GA; Liu L; Lim YC; Kim JM; Jung MG; Koo BS
    Oral Oncol; 2016 Jan; 52():66-74. PubMed ID: 26604082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
    Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
    J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis.
    Brunty S; Ray Wright K; Mitchell B; Santanam N
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33800594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial-mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract.
    Lu L; Luo F; Liu Y; Liu X; Shi L; Lu X; Liu Q
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):276-85. PubMed ID: 26415832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
    Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
    PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
    Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
    J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
    Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
    Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
    Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
    J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells.
    Jacksi M; Schad E; Tantos A
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3.
    Luo H; Jiang Y; Ma S; Chang H; Yi C; Cao H; Gao Y; Guo H; Hou J; Yan J; Sheng Y; Ren X
    Biochem Biophys Res Commun; 2016 Oct; 479(2):253-259. PubMed ID: 27638307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
    Shi Y; Xu L; Tao M; Fang L; Lu J; Gu H; Ma S; Lin T; Wang Y; Bao W; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2019 Mar; 316(3):F488-F505. PubMed ID: 30566000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition.
    Battistelli C; Cicchini C; Santangelo L; Tramontano A; Grassi L; Gonzalez FJ; de Nonno V; Grassi G; Amicone L; Tripodi M
    Oncogene; 2017 Feb; 36(7):942-955. PubMed ID: 27452518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-secreted Hsp90 subverts polycomb function to drive prostate tumor growth and invasion.
    Nolan KD; Franco OE; Hance MW; Hayward SW; Isaacs JS
    J Biol Chem; 2015 Mar; 290(13):8271-82. PubMed ID: 25670862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.